TBIO (Codex DNA) Return on Sales by Gross Profit

Corporate emblem and logo of Telesis Bio, Inc (TBIO)

Telesis Bio, Inc. (TBIO) leads in synthetic biology automation through its BioXp station and extensive R&D expenditures. Gross margin correlates with the adoption rate of benchtop synthesizers and demand for genetic engineering, while the 29.40 metric determines the status of the profitability parameter. The company's operations are strictly limited by FDA medical regulations and biomaterial disposal rules.

TBIO - Telesis Bio Gross Margin over the range 04/28/2023 - 10/05/2024

Comprehensive metric breakdowns and analytics for Codex DNA (TBIO)

Fundamental valuation:Telesis Bio, TBIO
Mass-produced product of Telesis Bio Inc.

Telesis Bio, Inc. (TBIO) leadership in synthetic biology automation via the BioXp station requires strict control over direct production costs. Gross margin measures the portion of revenue remaining after deducting the cost of goods sold, reflecting the efficiency of scaling technological innovations and the issuer's pricing power. An analysis of gross income allows an investor to assess the company's ability to convert R&D investments into operating profit.

Direct competitors

Return on Gross Profit Tempus AI Inc|QGEN (Qiagen NV) - Gross Margin|Return on Gross Profit Ionis Pharma (IONS)|Gross Profitability Repligen Corp (RGEN)|RNA - Gross Profit Margin|crisprtx.com - Return on Gross Profit|Gross Profit Rate WGS|RARE - Gross Profitability|Beam Tx (BEAM) - Return on Gross Profit|SRPT (Sarepta Therapeutics Inc) - Return on Gross Profit|TWST: Gross Profit Ratio|TXG (10xgenomics.com) - Gross Margin|NTLA (Intellia Therapeutics, Inc.) - Gross Profit Ratio|Gross Profitability Stoke Corp (STOK)|Return on Sales by Gross Profit BioLife|Gross Margin WVE (Wave Life Sciences Ltd)|MAZE: Gross Return on Sales|Sionna Therapeutics, Inc. - Gross Margin|Gross Profit Rate PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Return on Gross Profit|QURE - Return on Sales by Gross Profit|MGTX (MeiraGTx Corp) - Gross Margin|Gross Profit Margin REGENXBIO Inc. RGNX|Gross Profitability Solid Biosciences (SLDB)|Ocugen Corp - Gross Return on Sales|Gross Profitability Pacific Biosciences PACB|Gross Profit Ratio BNTC (Benitec)|Design Corp - Gross Margin|Rocket Pharmaceuticals - Gross Profit Ratio|Gross Return on Sales 4D Molecular Therapeutics, Inc.|Gross Profit Margin Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Gross Margin|Gross Profit Margin Editas EDIT|Gross Margin SLN|ProQR Therapeutics - Gross Return on Sales|Gross Margin CDXS (Codexis, Inc.)|SGMO: Gross Return on Sales|Nautilus Biotechnology - Gross Margin|Gross Profit Rate MGX (Metagenomi, Inc)|DTIL: Gross Margin|GBIO: Gross Profit Ratio|Gross Profitability Boundless Bio Inc.|Return on Gross Profit Exicure (XCUR)|Gross Margin IMNN|PHIO (Phio Pharmaceuticals Corp.) - Gross Profit Rate|Mustang Bio, Inc. - Return on Gross Profit|RNAZ - Return on Gross Profit|BNGO: Return on Gross Profit|APDN (Applied DNA Sciences Inc) - Gross Return on Sales|BLUE (Bluebird Bio) - Return on Gross Profit|ImmunoPrecise Antibodies Ltd - Gross Profit Rate|OMGA (Omega Therapeutics Inc) - Gross Margin|Gross Profitability OMIC|Gross Profitability Regulus Therapeutics Inc. (RGLS)|Return on Gross Profit Syros Pharmaceuticals, Inc. SYRS|Gross Profitability TRACON TCON|Unity Biotechnology, Inc - Gross Profitability